Real-time US stock institutional ownership tracking and fund flow analysis to understand who owns and is buying the stock. We monitor 13F filings and institutional buying patterns because large investors often have superior information.
As of April 6, 2026, Cardlytics Inc. (CDLX) trades at $1.2 per share, posting an intraday gain of 5.75% amid mild positive sentiment across small-cap technology names. This analysis outlines the current market context for the ad tech firm, key technical support and resistance levels to monitor, and potential near-term price scenarios based on prevailing market data. No fundamental earnings updates have been released for CDLX recently, so current price action is largely driven by technical dynami
Is Cardlytics (CDLX) Stock Expanding | Price at $1.20, Up 5.75% - High Conviction Picks
CDLX - Stock Analysis
4226 Comments
1124 Likes
1
Cebell
Power User
2 hours ago
Comprehensive US stock backtesting and historical performance analysis to validate investment strategies before committing capital. We provide extensive historical data that allows you to test any trading idea before risking real money.
👍 64
Reply
2
Vincil
Legendary User
5 hours ago
Investors are monitoring global and domestic news, contributing to fluctuating market sentiment.
👍 18
Reply
3
Shabri
Active Contributor
1 day ago
Could’ve made use of this earlier.
👍 231
Reply
4
Rosalynda
Elite Member
1 day ago
Overall trend remains upward, supported by market breadth.
👍 102
Reply
5
Bayze
Daily Reader
2 days ago
Read this twice, still acting like I get it.
👍 76
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.